FDA WARNING_LETTER - Eaglelionton Int"l Trading Co Inc - February 12, 2026

FDA WARNING_LETTER for Eaglelionton Int"l Trading Co Inc on February 12, 2026. Product: other. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA WARNING_LETTER for Eaglelionton Int"l Trading Co Inc on February 12, 2026. Product: other. Access full analysis and detailed observations.

Violation Codes

FD&C Act 805

FD&C Act 301(zz)

FD&C Act 801(a)(3)

21 CFR 21

21 U.S.C. 384a

21 U.S.C. 381(a)(3)

21 CFR 502(a)

21 U.S.C. 331(zz)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Eaglelionton Int"l Trading Co Inc

Inspection Date

February 12, 2026

Product Type

other

Office

Division of Northeast Imports

People

Joseph S. Tomao (Program Division Director)

ID: 02b0ad5b-f31e-4053-b46d-f9404cf78208

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox